While both drugs belong to the GLP-1 receptor agonist class, Mounjaro has a dual mechanism (GIP and GLP-1), which clinical ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

A new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...

To make your next trip easier, we reached out to three diabetes experts for their favorite tips for traveling with diabetes.

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

Weight loss jabs have recently gained a lot of popularity as they become more accessible to people through their general ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

What is Ozempic teeth? Here is what you need to know about how the weight loss drug Ozempic may be impacting your health.

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

Editorial: The health department rolling out jabs to patients who struggle with their weight must be a moment to rethink our ...